Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. (RARX) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 192 transactions totaling $158.2M, demonstrating a bullish sentiment with $130.3M in net insider flow. The most recent transaction on Apr 2, 2020 involved a transaction of 4,858,260 shares valued at $233.2M.
RARX Insider Activity Summary
Who Is Buying RARX Stock?
No significant insider buying has been recorded for RARX in the recent period.
Who Is Selling RARX Stock?
No significant insider selling has been recorded for RARX in the recent period.
Is Ra Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RARX is bullish with an Insider Alignment Score of 91/100 and a net flow of $130.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
RARX Frequently Asked Questions
Understanding RARX Insider Activity
Insider trading at Ra Pharmaceuticals, Inc. (RARX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading RARX stock, having executed 192 transactions in the past 90 days. The most active insider is Rajeev M. Shah (Executive), who has made 6 transactions totaling $265.9M.
Related Tools
Track Ra Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at RARX file new Form 4 transactions